Optimizing immunotherapy treatment for breast cancer patients

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1197509

Funding Status
Active

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The first steps in introducing immunotherapy for breast cancer patients have been taken in 2019. However, there is much work to do optimize immunotherapy for all breast cancer patients. My research, involving both lab and clinical trials, will develop new treatment strategies and identify new biomarkers to distinguish responders and non-responders. This will allow individualised selection of patients for evaluation of different immunotherapy approaches, with the aim of improving their survival.

Funded Activity Details

Start Date: 05-12-2019

End Date: End date not available

Funding Scheme: Investigator Grants

Funding Amount: $1,938,014.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

breast cancer | genomics | immunotherapy | translational research

Related Links